CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Therapeutics
  • Top Therapeutics Companies in Apac

Therapeutics 2023

Top 10 Therapeutics Companies in Apac – 2023

Top 10 Therapeutics Companies in Apac – 2023

Therapeutics improve clinical outcomes and reduce healthcare costs by combining technology with traditional medical approaches. AI and ML are being used to accelerate therapeutic discovery by analyzing vast amounts of data to optimize better services to the patient. Recent advancements in genomics and molecular profiling have enabled the identification of specific biomarkers that can guide treatment decisions. Nanotechnology allows for precise drug delivery to particular cells or tissues, enhancing the effectiveness of treatments while minimizing side effects. A therapeutic relationship between a healthcare professional and a patient is associated with improved patient satisfaction, adherence to treatment, and decreased levels of anxiety and depression.

The global Therapeutics market was valued at $3.16 bn in 2021 and is expected to grow at a value of $14.52 bn at a compound annual growth rate of 28.1 percent. Digital technology is used to prevent, manage, or treat medical conditions using evidence-based therapeutic interventions, growing the market. Therapeutics market growth is fueled by several factors, including a rising prevalence of chronic diseases, increased healthcare costs, and an increasing number of patients and healthcare providers accepting digital solutions. With advancements in neuroscience, new therapeutics are being developed for neurological disorders, driving the growth of this industry.

This edition of Life Sciences Review APAC brings insights into the latest developments in Therapeutics and how companies align with the current trends to improve patients' lives.

It features a thought leadership article from Clement Lim, Associate Director, Head of Early Cancer Detection, Scientific & Medical Affairs at Mirxes, who sheds light on how immunotherapy holds the promise of transforming cancer from a devastating diagnosis into a manageable and treatable disease, offering patients new hope and the prospect of a brighter tomorrow. It also features an article from Nelly Marmy Conus, DCT Manager, Decentralized Solutions at Syneos Health, who discusses the importance of ensuring stakeholders are given a detailed roadmap to outline how patients will be monitored in the decentralized approach.

In this edition of Life Sciences Review APAC, we also bring you stories of top therapeutics companies leveraging advanced technologies to improve patient care.

In this edition featuring the top Therapeutics Companies in APAC, South Korea, and Singapore 2023, we hope you find the right partner to deliver better patient treatment.

Top 10 Therapeutics Companies in Apac – 2023

Nominate a Company

Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.

* 

captcha
Can't read the image? click here to refresh

Thank You!

checkmark

We are glad to receive your nomination. Our editorial team and evaluation panel will review your submission. Thank you for taking the time to highlight an organization driving impactful change in Lifescience Review.

Data not inserted

    Top Therapeutics Companies in Apac

    ★Featured Companies
    Stella Pharma Corporation
    Stella Pharma Corporation
    Read full profile →
    Stella Pharma Corporation is a pharmaceutical company specializing in the research and development of drug products for boron neutron capture therapy (BNCT). As the primary purpose, the company has been aiming to expand and also gain recognition of BNCT as a novel modality of cancer treatment. Its unrelenting effort and passion for research have earned Steboronine®, the boron drug that Stella Pharma has been distributing since 2020, the tag of the world-first BNCT drug. ... read full profile
    Avania
    Avania
    Avania is an integrated global, full-service CRO with specialized expertise in medical device, novel technology, and combination products. Their proficiency spans feasibility to post-approval, covering analytics, trials, consulting, writing, quality, regulation, reimbursement, and beyond.
    Chimeric Therapeutics
    Chimeric Therapeutics
    Chimeric Therapeutics, a clinical-stage cell therapy firm, is dedicated to realizing the potential of cell therapy for a broader range of cancer patients. Their esteemed team of cell therapy visionaries is committed to uncovering, advancing, and introducing cutting-edge cell therapies to transform cancer treatment possibilities.
    Chordia Therapeutics
    Chordia Therapeutics
    Chordia Therapeutics, a pioneering biopharmaceutical company, focuses on innovative therapies for unmet medical needs. With a commitment to advancing healthcare, Chordia specializes in developing breakthrough treatments that harness cutting-edge technologies.
    Cynata Therapeutics
    Cynata Therapeutics
    Cynata Therapeutics is a pioneering biotechnology company. It specializes in developing innovative stem cell therapies for various medical conditions. Leveraging its proprietary Cymerus, a therapeutic stem cell platform technology, Cynata aims to revolutionize regenerative medicine by providing scalable and consistent sources of therapeutic stem cells to address unmet medical needs.
    CytoImmune Therapeutics
    CytoImmune Therapeutics
    CytoImmune's cohesive platform of biological and cellular therapeutic advancements empowers them to explore, create, produce, and bring to market an unparalleled range of regenerative medicines. Their strategy fosters targeted innovation and research, while also eliminating obstacles to knowledge and novel scientific discoveries.
    Kazia Therapeutics
    Kazia Therapeutics
    Kazia Therapeutics is an oncology-focused drug development company developing innovative treatments for various cancers. Through advanced research and strategic collaborations, they aim to provide new therapeutic solutions to patients worldwide. Their commitment to improving lives underscores their pursuit of groundbreaking oncology advancements.
    Protagonist Therapeutics
    Protagonist Therapeutics
    Protagonist Therapeutics is a pioneering biopharmaceutical company, focused on developing breakthrough peptide-based therapies. Leveraging innovative science, the company strives to target complex diseases with unmet medical needs. Their dedication to precision medicine and therapeutic innovation is showcased through a diverse pipeline of potential treatments, aiming to transform patients' lives.
    PTX Therapeutics
    PTX Therapeutics
    PTX Therapeutics is a clinical stage oncology company developing personalized medicine approaches to cancer, including targeted and cell therapies. With a commitment to precision medicine, PTX leverages cutting-edge research to create targeted therapies that address unmet needs.
    SPARK Biopharma
    SPARK Biopharma
    SPARK Biopharma is dedicated to forging breakthroughs in addressing unmet medical requirements. They envision harnessing molecularlevel insights into human diseases to establish a novel basis for developing pioneering small-molecule therapeutics. This involves the seamless amalgamation of biology, chemistry, proteomics, and informatics for the advancement of medical solutions.
Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://therapeutics-apac.lifesciencesreview.com/vendors/top-therapeutics-companies-in-apac-2023.html